Healthcare AI Company Market Map
Medical Imaging and Diagnostic AI
Systems that analyze radiology, pathology, and cardiology images and flag findings for clinician review.
Buyer Brief
- Best-fit buyer
- Radiology leadership, pathology leadership, clinical informatics, imaging IT, patient safety, and procurement
- Primary use case
- Triage studies, flag findings, support image interpretation, and coordinate time-sensitive care
- Typical deployment
- Usually integrated with PACS, RIS, worklists, or digital pathology systems and monitored inside the clinical workflow
Regulatory clearance is only the starting point. Local performance, workflow fit, alert burden, failure handling, and the exact authorized use determine whether a tool is useful in a specific department.
Companies in This Category
| Company | What it does | Research next |
|---|---|---|
| Aidoc | Radiology triage AI that flags suspected acute findings such as intracranial hemorrhage and pulmonary embolism to move them up the read list. One of the larger FDA-cleared portfolios in imaging triage. | Clinical profile Official site |
| Viz.ai | Care coordination built on imaging AI: detects suspected large vessel occlusion stroke and alerts the intervention team directly, compressing time-to-treatment rather than only flagging the scan. | Clinical profile Official site |
| PathAI | AI for digital pathology, applied to both diagnostic support and pharmaceutical research workflows where consistent slide interpretation is the bottleneck. | Clinical profile Official site |
| Lunit | Imaging AI concentrated in mammography screening and chest radiography, with a significant deployment base in national screening programs outside the United States. | Buyer profile Official site |
| Annalise.ai | Comprehensive chest X-ray and head CT AI that reports across a wide list of findings simultaneously, rather than detecting one pathology per model. | Buyer profile Official site |
| RapidAI | Neurovascular imaging analysis for stroke and aneurysm workflows, widely embedded in comprehensive stroke center protocols. | Buyer profile Official site |
What to Verify Before Shortlisting
Evidence
- Was the tool tested prospectively and independently on comparable equipment and patients?
- What are sensitivity, specificity, false positive workload, and time-to-action effects?
- How does performance vary by site, scanner, demographic subgroup, and disease prevalence?
Regulatory and workflow
- Which FDA authorization covers the exact product version, modality, and intended use?
- Who retains final clinical responsibility and how is disagreement with the AI handled?
- What post-deployment monitoring and material update notification does the vendor provide?
Data and contracts
- Where are images and derived data processed and retained?
- Which PACS, RIS, pathology, and EHR integrations are supported in production?
- Can data be used for model improvement, and what controls govern secondary use?
The question that matters: Which specific FDA clearance covers which specific finding on which specific modality. A clearance for one use case is not validation for everything the marketing page implies.
Directory inclusion is editorial and does not imply endorsement. Product capabilities, contracts, and regulatory status can change. Verify claims with the company and the relevant regulator before procurement.